Article
Increased concentrations of IL-18 and uric acid in sickle cell anemia: contribution of hemolysis, endothelial activation and the inflammasome.
Registro en:
CERQUEIRA, B. A. V. et al. Increased concentrations of IL-18 and uric acid in sickle cell anemia: contribution of hemolysis, endothelial activation and the inflammasome. Cytokine, v. 56, n. 2, p. 471-476, 2011.
1096-0023
:10.1016/j.cyto.2011.08.013
Autor
Cerqueira, Bruno Antonio Veloso
Santos, Wendell Vilas Boas
Zanette, Angela Maria Dias
Reis, Mitermayer Galvão dos
Gonçalves, Marilda de Souza
Resumen
Sickle cell anemia (SCA) is a common, severe monogenetic disorder characterized by chronic hemolysis,
frequent infections, a chronic inflammatory state and recurrent occlusions of the microcirculation, resulting
in painful crises, organ damage and premature death. This study evaluated associations between
serum levels of IL-18, uric acid, hemolytic markers, and inflammatory molecules in SCA patients. A
cross-sectional study was performed including 45 SCA patients (median age of 20.5 years) without general
symptoms and who had not undergone blood transfusions. Inclusion criteria for the steady-state SCA
patients were the absence of hospitalization and the absence of infections. Interleukin-18 and uric acid
levels were correlated closely with markers of hemolysis, endothelial dysfunction and others cytokines
levels. These findings suggest probable influences of IL-18 and uric acid in the pathophysiology of vascular
occlusion in SCA. Additional studies should be performed to characterize similar prognosis markers
and possible therapeutic targets.